DGI:Lymeborreliose/Quellen: Difference between revisions

From Infektiopedia
imported>Brinkery
(Die Seite wurde neu angelegt: „Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. ''Infect Dis Clin North Am''. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004 Steere AC, A…“)
 
imported>Brinkery
No edit summary
Line 1: Line 1:
Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. ''Infect Dis Clin North Am''. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004
== Quellen ==


Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. ''Arthritis Rheum''. 2006;54(10):3079-3086. doi:10.1002/art.22131
* Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. ''Infect Dis Clin North Am''. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004
* Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. ''Arthritis Rheum''. 2006;54(10):3079-3086. doi:10.1002/art.22131
* Grillon A, Scherlinger M, Boyer PH, et al. Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis. ''Semin Arthritis Rheum''. 2019;48(6):1105-1112. doi:10.1016/j.semarthrit.2018.09.007


Grillon A, Scherlinger M, Boyer PH, et al. Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis. ''Semin Arthritis Rheum''. 2019;48(6):1105-1112. doi:10.1016/j.semarthrit.2018.09.007
 
Therapie:
 
*  <span class="ve-pasteProtect" style="box-sizing: inherit; font-family: Arial, sans-serif;" data-ve-attributes="{&quot;style&quot;:&quot;box-sizing: inherit; font-family: Arial, sans-serif;&quot;}">Hofmann H, et al. ''S2k-Leitlinie Kutane Lyme Borreliose'', 2016</span>
* <span class="ve-pasteProtect" style="box-sizing: inherit; font-family: Arial, sans-serif;" data-ve-attributes="{&quot;style&quot;:&quot;box-sizing: inherit; font-family: Arial, sans-serif;&quot;}">Rauer S, Kastenbauer S. ''S3-Leitlinie Neuroborreliose'', 2018</span>
* Kullberg BJ, et al., ''Lyme borreliosis: diagnosis and treatment.'' <span class="ve-pasteProtect" style="box-sizing: inherit; font-family: Arial, sans-serif;" data-ve-attributes="{&quot;style&quot;:&quot;box-sizing: inherit; font-family: Arial, sans-serif;&quot;}">BMJ, 2020. 369:m1041. <span class="ve-pasteProtect" style="color: black" data-ve-attributes="{&quot;style&quot;:&quot;color: black&quot;}">doi: 10.1136/bmj.m1041.</span> <span class="ve-pasteProtect" style="box-sizing: inherit;" data-ve-attributes="{&quot;style&quot;:&quot;box-sizing: inherit;&quot;}"> </span></span>
* <span class="ve-pasteProtect" style="box-sizing: inherit; font-family: Arial, sans-serif;" data-ve-attributes="{&quot;style&quot;:&quot;box-sizing: inherit; font-family: Arial, sans-serif;&quot;}">Gaubitz M, et al., ''Empfehlungen der DGRh zur Therapie der Lyme-Borreliose, speziell des Erythema migrans sowie der Lyme-''</span>
* NICE guideline 2018: ''Lyme disease''
* Goodlet KJ, Fairman KA. ''Adverse Events Associated With Antibiotics and Intravenous Therapies for Post–Lyme Disease Syndrome in a Commercially Insured Sample.'' <span class="ve-pasteProtect" style="box-sizing: inherit; font-family: Arial, sans-serif;" data-ve-attributes="{&quot;style&quot;:&quot;box-sizing: inherit; font-family: Arial, sans-serif;&quot;}">Clin Infect Dis, 2018; 67(10):1568-1574</span>
 
<br />

Revision as of 13:04, 10 December 2020

Quellen

  • Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004
  • Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006;54(10):3079-3086. doi:10.1002/art.22131
  • Grillon A, Scherlinger M, Boyer PH, et al. Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis. Semin Arthritis Rheum. 2019;48(6):1105-1112. doi:10.1016/j.semarthrit.2018.09.007


Therapie:

  • Hofmann H, et al. S2k-Leitlinie Kutane Lyme Borreliose, 2016
  • Rauer S, Kastenbauer S. S3-Leitlinie Neuroborreliose, 2018
  • Kullberg BJ, et al., Lyme borreliosis: diagnosis and treatment. BMJ, 2020. 369:m1041. doi: 10.1136/bmj.m1041.  
  • Gaubitz M, et al., Empfehlungen der DGRh zur Therapie der Lyme-Borreliose, speziell des Erythema migrans sowie der Lyme-
  • NICE guideline 2018: Lyme disease
  • Goodlet KJ, Fairman KA. Adverse Events Associated With Antibiotics and Intravenous Therapies for Post–Lyme Disease Syndrome in a Commercially Insured Sample. Clin Infect Dis, 2018; 67(10):1568-1574


Retrieved from "https://wiki.cakele.iodatalabs.dev/index.php?title=DGI:Lymeborreliose/Quellen&oldid=1130"